Loratadine D 45802-0122
Generic: Loratadine, Pseudoephedrine Sulfate
Product NDC
45802-0122- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- April 10, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA076050
Active Ingredients
| Ingredient | Strength |
|---|---|
| Loratadine | 5 mg/1 |
| Pseudoephedrine Sulfate | 120 mg/1 |
Drug Class
Adrenergic alpha-Agonists [MoA]alpha-Adrenergic Agonist [EPC]
Packaging Options(3)
10 BLISTER PACK in 1 CARTON (45802-122-46) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
20 BLISTER PACK in 1 CARTON (45802-122-60) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
30 BLISTER PACK in 1 CARTON (45802-122-65) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK